AstraZeneca appoints Sharon Barr as Executive Vice President BioPharmaceuticals R&D

AstraZeneca today announced the appointment of Sharon Barr as Executive Vice President, BioPharmaceuticals R&D. Sharon will succeed Mene Pangalos, who is retiring and will step down from his role early next year, after almost fourteen years with the company and an illustrious 35-year career.

read more

Breathing hope: Tackling lung cancer in Africa and the Middle East

Lung cancer, once rare, is now the highest cause of mortality of cancer worldwide. Responsible for more fatalities than breast, colon, and prostate cancers combined. [1] It claims a life every 18 seconds. In recent years, wealthier countries have recently experienced a significant decline in lung cancer mortality, but in most of the Middle East and Africa incidence and mortality remains high.

read more